Formamide

Formamide

SCHEMBL23320428

Cc1c(-c2ccccc2)n(C)c2ccc(NC(=O)NCc3ccccn3)cc12.NC=O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ KMT2A Q03164 4/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ NPC1 O15118 4/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ GLA P06280 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ TSHR P16473 1/20 0.48
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ SHMT2 P34897 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL23320515 0.87 NAMPT (0.52) HTT
Formamide SCHEMBL23320541 0.78 ALDH1A1 (0.48) KMT2ATSHR
SCHEMBL20380104 0.70 L3MBTL1 (1.00) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1
SCHEMBL11618998 0.70 RAB9A (1.00) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1
SCHEMBL8936567 0.67 TACR1 (0.74) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1
Formamide SCHEMBL23320507 0.67 ALDH1A1 (0.62) L3MBTL1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL17117408 0.66 RORC (0.61) KMT2ANPC1RAB9AMAPTCA12
SCHEMBL30818065 0.66 NPC1 (0.78) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1
SCHEMBL20379469 0.66 NPC1 (0.78) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1
SCHEMBL18317596 0.66 RAB9A (0.80) L3MBTL1KMT2ASMN1; SMN2ALOX15NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3818053-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-05-12 — — EP disclosed
Send feedback